Navigation Links
Calvert Research Licenses Novel Technology to Treat Age Related Macular Degeneration from Tulane University
Date:6/10/2009

Calvert Research, LLC (a unit of Calvert Holdings, Inc.) today announced the execution of a license agreement with Tulane University granting Calvert Research (through its wholly owned subsidiary, Calvert T1, LLC) certain rights to issued patents and patent applications covering a technology platform and novel compounds which have the potential to treat a debilitating eye disease known as Age-related Macular Degeneration (AMD).

Cary, NC (PRWEB) June 9, 2009 -- Calvert Research, LLC (a unit of Calvert Holdings, Inc.) today announced the execution of a license agreement with Tulane University granting Calvert Research (through its wholly owned subsidiary, Calvert T1, LLC) certain rights to issued patents and patent applications covering a technology platform and novel compounds which have the potential to treat a debilitating eye disease known as Age-related Macular Degeneration (AMD). The patented compounds and technology licensed by Calvert T1 were developed in the laboratory of Dr. David H. Coy and his team at the Peptide Research Laboratory at Tulane University.

AMD is a leading cause of blindness in the elderly, affecting millions worldwide and results from the progressive deterioration of the macula, which are the light-sensitive cells of the central retina at the back of the eye. AMD is characterized by two types: a dry (atrophic) and wet (exudative) form. Wet AMD occurs when abnormal blood vessels behind the retina begin to grow under the macula, often leaking blood and fluid that can lead to visual distortions, a decrease or loss of central vision, and eventual blindness.

The preclinical stage compounds license
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. Calvert Research and Auburn University Announce Joint Venture
2. Calvert Labs Announces the Hiring of Terry Ladd
3. Calvert Research and CureDM Sign Collaborative Agreement
4. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
5. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
6. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
7. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
8. Dawson James Securities Initiates Research Coverage on CryoCor, Inc. (Nasdaq: CRYO) with a Strong Buy Rating and $6.00 Target Price
9. eResearchTechnology to Present at the Thomas Weisel Healthcare Conference 2007 on September 5th
10. The Debiopharm Life Sciences Award Goes to Dr Nusser for his Outstanding Research in Neuroscience
11. Study Published in Clinical Cancer Research Confirms Potential Of Peregrines Bavituximab Combined With Radiation In Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Calvert Research Licenses Novel Technology to Treat Age Related Macular Degeneration from Tulane University
(Date:3/27/2015)... , March 27, 2015 WuXi PharmaTech ... open-access R&D capability and technology platform company serving ... announced today that an Investigational New Drug (IND) ... for rheumatoid arthritis has been accepted for review ... In September 2012, MedImmune, the ...
(Date:3/26/2015)... 26, 2015  Roka Bioscience, Inc. (NASDAQ: ... providing advanced testing solutions for the detection of ... the three months and full year ended December ... Results:Revenue for the quarter ended December 31, 2014 ... fourth quarter of 2013 and $1.5 million for ...
(Date:3/26/2015)... 2015 The Market Element LLC, a ... alliance with Designing Gig LLC to provide website design, ... , “Forging this alliance with Designing Gig represents a ... extend a comprehensive, end-to-end, digital solution for our clients, ... said Chuck Miller, president of The Market Element. “For ...
(Date:3/26/2015)... Neogen Corporation (NASDAQ: NEOG ) announced ... of fiscal 2015, which ended Feb. 28, increased 13% ... Earnings per share in the current quarter were $0.20, ... income increased 17% over prior year to $24,142,000, or ... share, for the same period a year ago. ...
Breaking Biology Technology:Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 2Investigational New Drug Application for WuXi MedImmune's Monoclonal Antibody Accepted for Review by CFDA 3Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 2Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 3Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 4Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 5Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 6Roka Bioscience Reports Fourth Quarter and Full Year 2014 Financial Results 7The Market Element LLC and Designing Gig LLC Form Strategic Alliance 2Neogen reports 13% increase in net income 2Neogen reports 13% increase in net income 3Neogen reports 13% increase in net income 4Neogen reports 13% increase in net income 5Neogen reports 13% increase in net income 6Neogen reports 13% increase in net income 7Neogen reports 13% increase in net income 8
... Leader Strengthens Scaffold-Engineering Capabilities ... Electrospinning Platform Technology & Team, CANTON, Mass. ... the world,s most successful regenerative medicine,company, announced today ... NanoMatrix,s platform technology develops "designer scaffolds" for the,purposes ...
... latest Rainbow SET(R) parameter at the upcoming World ... Congress of Anesthesiologists ... inventor,of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low Perfusion ... for,noninvasive and continuous total hemoglobin (SpHb(TM)) and oxygen content,(SpOC(TM)) ...
... t2cure, a clinical,stage biopharmaceutical company developing novel ... that it has appointed,Dr. Petra Rueck Head of ... Petra join our company", said Manfred Ruediger,CEO of ... will be of critical importance to t2cure as ...
Cached Biology Technology:Organogenesis, Inc. Announces Acquisition of NanoMatrix, Inc. 2Organogenesis, Inc. Announces Acquisition of NanoMatrix, Inc. 3Masimo Announces Continuous Noninvasive Total Hemoglobin 2Masimo Announces Continuous Noninvasive Total Hemoglobin 3Masimo Announces Continuous Noninvasive Total Hemoglobin 4Stem Cell Company t2cure Appoints Dr Rueck Head of Clinical Operations 2
(Date:3/17/2015)... YORK , March 17, 2015  MecklerMedia ... the largest exhibition for service robots ever held ... RoboUniverse takes place on May 11-13, 2015 at ... and exhibitors for the event include: Acorn Product ... Control; EZ-Robot; Infranor; Kinova Robotics; Littler; NewBotic Corporation; ...
(Date:3/12/2015)... March 12, 2015 WHEN:Tuesday, March 17, 2015 ... http://bit.ly/1G7Os0L . SPEAKERS: , Frost & Sullivan ... http://photos.prnewswire.com/prnh/20150311/181111 Biometric companies must ... in several different markets and industries. This is ... an uptrend. Join Frost & ...
(Date:3/10/2015)... PROVO, Utah , March 10, 2015   ... genome interpretation, has been selected by next-generation sequencing company ... provider of whole exome and targeted gene panel interpretation. ... sequencing provider, has adopted the most current technologies to ... of genetic research. The company offers two types of ...
Breaking Biology News(10 mins):MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 2PrimBio Research Selects Tute as Whole Exome Analysis Provider, Creating Integrated, End-to-End Solution for Next-Generation Sequencing & Data Analysis 3
... advance vaccines for related viruses including dengue fever. A ... West Nile virus has an intriguing secret: Contrary to ... to attach to host cells. Instead, the antibody somehow ... , "This was a complete surprise to us, but ...
... compound derived from cottonseed could help improve the effectiveness ... at the University of Michigan Comprehensive Cancer Center have ... issue of the journal Molecular Cancer Therapeutics, could lead ... surgically removing the cancer, helping patients preserve vital organs ...
... McKnight Brain Institute have created a system in rodent ... the process of generating new brain cells -- in ... of the National Academy of Sciences, researchers describe a ... a limitless supply of a person's own brain cells ...
Cached Biology News:Secrets to antibody's success against West Nile Virus surprise scientists 2Secrets to antibody's success against West Nile Virus surprise scientists 3Secrets to antibody's success against West Nile Virus surprise scientists 4Compound from Chinese medicine shows promise in head and neck cancer 2Compound from Chinese medicine shows promise in head and neck cancer 3For first time, brain cells generated in a dish 2For first time, brain cells generated in a dish 3
...
Mouse monoclonal [RL13] to LAP1 ( Abpromise for all tested applications). SwissProtID: Q96NW7...
CircuLex Anti-Human S100P Polyclonal Antibody Research Focus: proliferation Storage: -20C Shipping Temperature: 4C...
Mouse monoclonal [7E10] to C Peptide ( Abpromise for all tested applications). entrezGeneID: 3630 SwissProtID: P01308...
Biology Products: